Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics
Hu Zhu(National Center for Advancing Translational Sciences), Ruili Huang(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute), Menghang Xia(National Center for Advancing Translational Sciences), Anton Simeonov(National Institutes of Health), Srilatha Sakamuru(National Institutes of Health), Jinghua Zhao(Sun Yat-sen University), Deborah K. Ngan(National Institutes of Health), Mathew D. Hall(National Institutes of Health), Catherine Z. Chen(National Institutes of Health)
Cited by 31
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Erratum: Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|327